![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 28, 26708-26714, July 13, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
From the Molecular Pharmacology Department, St. Jude Children's
Research Hospital, Memphis, Tennessee 38105
DNA topoisomerases play essential roles in many
DNA metabolic processes. It has been suggested that topoisomerases play
an essential role in DNA repair. Topoisomerases can introduce DNA damage upon exposure to drugs that stabilize the covalent
protein-DNA intermediate of the topoisomerase reaction. Lesions
in DNA are also able to trap topoisomerase-DNA intermediates,
suggesting that topoisomerases have the potential to either assist in
DNA repair by locating sites of damage or exacerbating DNA damage by
generation of additional damage at the site of a lesion. We have shown
that overexpression of yeast topoisomerase I (TOP1) conferred hypersensitivity to methyl methanesulfonate and other DNA-damaging agents, whereas expression of a catalytically inactive enzyme did not. Overexpression of topoisomerase II did not change the
sensitivity of cells to these DNA-damaging agents. Yeast cells lacking
TOP1 were not more resistant to DNA damage than cells expressing wild type levels of the enzyme. Yeast topoisomerase I
covalent complexes can be trapped efficiently on UV-damaged DNA. We
suggest that TOP1 does not participate in the repair of DNA
damage in yeast cells. However, the enzyme has the potential of
exacerbating DNA damage by forming covalent DNA-protein complexes at
sites of DNA damage.
To whom correspondence should be addressed: Molecular Pharmacology
Department, St. Jude Children's Research Hospital, 332 N. Lauderdale
St., Memphis TN 38105. Tel.: 901-495-2794; Fax: 901-521-1668; E-mail:
john.nitiss@stjude.org.
This article has been cited by other articles:
![]() |
L. Tian, J. M. Sayer, D. M. Jerina, and S. Shuman Individual Nucleotide Bases, Not Base Pairs, Are Critical for Triggering Site-specific DNA Cleavage by Vaccinia Topoisomerase J. Biol. Chem., September 17, 2004; 279(38): 39718 - 39726. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Daroui, S. D. Desai, T.-K. Li, A. A. Liu, and L. F. Liu Hydrogen Peroxide Induces Topoisomerase I-mediated DNA Damage and Cell Death J. Biol. Chem., April 9, 2004; 279(15): 14587 - 14594. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Malik and J. L. Nitiss DNA Repair Functions That Control Sensitivity to Topoisomerase-Targeting Drugs Eukaryot. Cell, February 1, 2004; 3(1): 82 - 90. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Z. K. Fagundes, L. Fernandes, M. Savoldi, S. D. Harris, M. H. S. Goldman, and G. H. Goldman Identification of a Topoisomerase I Mutant, scsA1, as an Extragenic Suppressor of a Mutation in scaANBS1, the Apparent Homolog of Human Nibrin in Aspergillus nidulans Genetics, July 1, 2003; 164(3): 935 - 945. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pourquier, C. Gioffre, G. Kohlhagen, Y. Urasaki, F. Goldwasser, L. W. Hertel, S. Yu, R. T. Pon, W. H. Gmeiner, and Y. Pommier Gemcitabine (2',2'-Difluoro-2'-Deoxycytidine), an Antimetabolite That Poisons Topoisomerase I Clin. Cancer Res., August 1, 2002; 8(8): 2499 - 2504. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |